Strs Ohio Purchases 92,214 Shares of Amdocs Limited (NASDAQ:DOX)

Strs Ohio raised its position in Amdocs Limited (NASDAQ:DOXFree Report) by 296.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 123,292 shares of the technology company’s stock after buying an additional 92,214 shares during the quarter. Strs Ohio owned about 0.10% of Amdocs worth $11,839,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in DOX. Dimensional Fund Advisors LP raised its stake in shares of Amdocs by 3.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,937,605 shares of the technology company’s stock valued at $176,128,000 after purchasing an additional 66,677 shares during the period. American Century Companies Inc. raised its stake in shares of Amdocs by 36.1% during the 4th quarter. American Century Companies Inc. now owns 1,753,115 shares of the technology company’s stock valued at $159,358,000 after purchasing an additional 464,732 shares during the period. Arrowstreet Capital Limited Partnership raised its stake in shares of Amdocs by 2.0% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,722,404 shares of the technology company’s stock valued at $156,567,000 after purchasing an additional 33,286 shares during the period. State Street Corp raised its stake in shares of Amdocs by 1.7% during the 1st quarter. State Street Corp now owns 1,648,032 shares of the technology company’s stock valued at $136,136,000 after purchasing an additional 28,269 shares during the period. Finally, Morgan Stanley grew its position in Amdocs by 13.0% during the fourth quarter. Morgan Stanley now owns 1,314,372 shares of the technology company’s stock worth $119,477,000 after buying an additional 151,601 shares in the last quarter. 93.42% of the stock is currently owned by institutional investors.

Amdocs Price Performance

DOX opened at $97.08 on Friday. Amdocs Limited has a 12-month low of $78.02 and a 12-month high of $99.75. The stock has a market capitalization of $11.73 billion, a P/E ratio of 22.11, a PEG ratio of 1.66 and a beta of 0.66. The stock has a 50-day moving average price of $95.26 and a 200-day moving average price of $93.58. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21.

Amdocs (NASDAQ:DOXGet Free Report) last announced its earnings results on Wednesday, May 10th. The technology company reported $1.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.32 by $0.01. Amdocs had a return on equity of 16.92% and a net margin of 11.33%. The firm had revenue of $1.22 billion during the quarter, compared to analyst estimates of $1.22 billion. Equities analysts predict that Amdocs Limited will post 5.34 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 28th. Investors of record on Friday, June 30th will be given a dividend of $0.435 per share. This represents a $1.74 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date of this dividend is Thursday, June 29th. Amdocs’s dividend payout ratio (DPR) is presently 39.64%.

Analyst Ratings Changes

DOX has been the subject of several recent analyst reports. StockNews.com initiated coverage on Amdocs in a research report on Thursday, May 18th. They set a “buy” rating for the company. 888 restated a “reiterates” rating on shares of Amdocs in a research report on Thursday, May 11th. Bank of America boosted their target price on Amdocs from $100.00 to $110.00 in a research report on Friday, June 16th. Finally, Barclays upgraded Amdocs from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $100.00 to $115.00 in a research report on Tuesday, May 16th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $104.00.

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES21, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; the Commerce and Care suite for order capture, handling, and customer engagement; the Monetization suite for charging, billing, policy, and revenue management; Intelligent Networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; MarketONE, a cloud-native business ecosystem; Digital Brands Suite, a pre-integrated digital business suite for digital telecom brands and small-scale service providers; and eSIM Cloud for service providers.

Recommended Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.